GE Stock Surges 31.74% to 450th in Market Rankings as GE HealthCare's Aurora SPECT/CT System Gains FDA Clearance
On May 27, 2025, GE's trading volume reached 2.26 billion, marking a 31.74% increase from the previous day, placing it 450th in the day's stock market rankings. GE HealthCareGEHC-- (GEHC) rose by 2.67%.
GE HealthCare has secured FDA 510(k) clearance for its innovative dual-head SPECT/CT system, AuroraAUR--, along with its advanced Clarify DL image reconstruction technology. This clearance is a significant milestone for the company, as it enhances its capabilities in diagnostic imaging.
The Aurora SPECT/CT system, when combined with AI-enabled Clarify DL image reconstruction, has the potential to offer enhanced image quality. This advancement is particularly beneficial for women's health diagnostic imaging, providing more accurate and detailed results.
Comentarios
Aún no hay comentarios